Mersana Therapeutics buy Citigroup Inc.
Start price
04.12.23
/
50%
€1.71
Target price
04.12.24
€4.61
Performance (%)
24.39%
Price
30.05.24
€2.15
Summary
This prediction is currently active. The prediction currently has a performance of 24.39%. This prediction currently runs until 04.12.24. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mersana Therapeutics | -1.825% | -1.825% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by Citigroup_Inc_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock, up previously from $1.00.
Ratings data for MRSN provided by MarketBeat